✦ LIBER ✦

High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: Pattern of failure and implications for involved-field radiotherapy

✍ Scribed by Arno J. Mundt; Stephanie F. Williams; Dennis Hallahan

Book ID: 108435711
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 963 KB
Volume: 39
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(97)00379-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Consolidative involved field radiotherap

Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study

✍ Christoph Oehler-Jänne; Christian Taverna; Nadine Stanek; Laura Negretti; Urs M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract The role of involved field radiation therapy (IF‐RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non‐Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IF‐RT. A

Patterns of failure following high dose

Patterns of failure following high dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease

✍ A.J. Mundt; Gregory Sibley; Stephanie Williams; Dennis Hallahan; Ralph Weichselb 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Does the Addition of Involved Field Radi

Does the Addition of Involved Field Radiotherapy to High-dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients with Relapsed/Refractory Hodgkin Lymphoma?

✍ Kahn, S.T.; Flowers, C.; Xu, Z.; Esiashvili, N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

43 EFFICACY OF LOW-DOSE INVOLVED-FIELD R

43 EFFICACY OF LOW-DOSE INVOLVED-FIELD RADIOTHERAPY FOLLOWING 3-4 CYCLES OF CHEMOTHERAPY FOR PATIENTS WITH STAGE I-II AGGRESSIVE NON-HODGKIN'S LYMPHOMA

✍ Gauthier, I.; Després, P.; Roy, I. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Treatment outcome and prognostic factors

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin’s lymphoma

✍ Lee, S M; Ryder, W D J; Clemons, M J; Morgenstern, G R; Chang, J; Scarffe, J H; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Yttrium-90–ibritumomab tiuxetan (Zevalin

Yttrium-90–ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma

✍ Avichai Shimoni; S. Tzila Zwas; Yakov Oksman; Izhar Hardan; Noga Shem-Tov; Ronit 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 186 KB